Follow
Edwin Posadas
Edwin Posadas
Medical Director, Urologic Oncology Program; Director, Translational Oncology Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Verified email at csmc.edu
Title
Cited by
Cited by
Year
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity
NS Azad, EM Posadas, VE Kwitkowski, SM Steinberg, L Jain, ...
Journal of Clinical Oncology 26 (22), 3709-3714, 2008
3822008
Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma
T Vagner, C Spinelli, VR Minciacchi, L Balaj, M Zandian, A Conley, ...
Journal of extracellular vesicles 7 (1), 1505403, 2018
3532018
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
2792017
Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
JC Ahn, PC Teng, PJ Chen, E Posadas, HR Tseng, SC Lu, JD Yang
Hepatology 73 (1), 422-436, 2021
2722021
Large oncosomes mediate intercellular transfer of functional microRNA
M Morello, V Minciacchi, P de Candia, J Yang, E Posadas, H Kim, ...
Cell cycle 12 (22), 3526-3536, 2013
2492013
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer
EY Yu, G Wilding, E Posadas, M Gross, S Culine, C Massard, MJ Morris, ...
Clinical Cancer Research 15 (23), 7421-7428, 2009
2462009
Targeted therapies for renal cell carcinoma
EM Posadas, S Limvorasak, RA Figlin
Nature Reviews Nephrology 13 (8), 496-511, 2017
2412017
Fyn: a novel molecular target in cancer
YD Saito, AR Jensen, R Salgia, EM Posadas
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
2372010
Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis
S Josson, M Gururajan, SY Sung, P Hu, C Shao, HE Zhau, C Liu, ...
Oncogene 34 (21), 2690-2699, 2015
2212015
Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a …
KA Autio, R Dreicer, J Anderson, JA Garcia, A Alva, LL Hart, MI Milowsky, ...
JAMA oncology 4 (10), 1344-1351, 2018
2162018
A phase II clinical trial of sorafenib in androgen-independent prostate cancer
WL Dahut, C Scripture, E Posadas, L Jain, JL Gulley, PM Arlen, JJ Wright, ...
Clinical cancer research 14 (1), 209-214, 2008
2122008
High‐purity prostate circulating tumor cell isolation by a polymer nanofiber‐embedded microchip for whole exome sequencing
L Zhao, YT Lu, F Li, K Wu, S Hou, J Yu, Q Shen, D Wu, M Song, ...
Advanced materials 25 (21), 2897-2902, 2013
1762013
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
EM Posadas, MS Liel, V Kwitkowski, L Minasian, AK Godwin, MM Hussain, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
1752007
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ...
Nature communications 11 (1), 4489, 2020
1692020
Dasatinib combined with docetaxel for castration‐resistant prostate cancer: results from a phase 1‐2 study
JC Araujo, P Mathew, AJ Armstrong, EL Braud, E Posadas, M Lonberg, ...
Cancer 118 (1), 63-71, 2012
1682012
Proteomic analysis for the early detection and rational treatment of cancer—realistic hope?
EM Posadas, F Simpkins, LA Liotta, C MacDonald, EC Kohn
Annals of oncology 16 (1), 16-22, 2005
1622005
NanoVelcro Chip for CTC enumeration in prostate cancer patients
YT Lu, L Zhao, Q Shen, MA Garcia, D Wu, S Hou, M Song, X Xu, ...
Methods 64 (2), 144-152, 2013
1562013
MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer
VR Minciacchi, C Spinelli, M Reis-Sobreiro, L Cavallini, S You, M Zandian, ...
Cancer research 77 (9), 2306-2317, 2017
1522017
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer
S Josson, M Gururajan, P Hu, C Shao, GCY Chu, HE Zhau, C Liu, K Lao, ...
Clinical cancer research 20 (17), 4636-4646, 2014
1522014
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review
G Leonard, E Posadas, P Herrmann, V Anderson, E Jaffe, S Holland, ...
Leukemia & lymphoma 45 (12), 2521-2525, 2004
1302004
The system can't perform the operation now. Try again later.
Articles 1–20